Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision on the page updated from v3.6.0 to v3.6.3, representing a minor update to the page version without altering core study details.
    Difference
    0.0%
    Check dated 2026-06-30T01:24:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note to reflect a page update.
    Difference
    0.3%
    Check dated 2026-06-15T19:13:12.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a backend/page-system update. This does not modify the study data or visible content.
    Difference
    0.0%
    Check dated 2026-06-08T15:14:05.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study location list was updated to add Taebuk, South Korea (28644) and remove Jungbuk, South Korea (28644); the page revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.4%
    Check dated 2026-05-18T03:24:36.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page footer to reflect a newer software/version revision (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T13:45:42.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T05:19:39.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.